These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7045983)

  • 1. Hypoglycaemic drugs.
    Sarges R
    Prog Med Chem; 1981; 18():191-223. PubMed ID: 7045983
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral hypoglycaemic drugs: clinical pharmacology and therapeutic use.
    Stowers JM; Borthwick LJ
    Drugs; 1977 Jul; 14(1):41-56. PubMed ID: 328260
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical pharmacology and rational therapeutic use of antidiabetic drugs].
    Giraudo JR
    Rev Fac Cien Med Univ Nac Cordoba; 1979; 37(1-4):28-33. PubMed ID: 556116
    [No Abstract]   [Full Text] [Related]  

  • 4. Rational use of oral hypoglycaemic drugs.
    Taft P
    Drugs; 1979 Feb; 17(2):134-9. PubMed ID: 456290
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic effects of oral hypoglycemic drugs.
    Davidoff F
    Fed Proc; 1977 Dec; 36(13):2724-7. PubMed ID: 336410
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral hypoglycemic agents: the pharmacological basis of their clinical use.
    Davidoff F
    R I Med J; 1973 Oct; 56(10):409-14. PubMed ID: 4518221
    [No Abstract]   [Full Text] [Related]  

  • 7. Sulphonylureas and biguanides do not affect insulin binding in H35 hepatoma cells.
    De Vries CP; van der Veen EA
    Diabetes Res; 1986 Jul; 3(6):307-10. PubMed ID: 3757414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of biguanides and sulfonylureas on insulin receptors in cultured cells.
    Goldfine ID; Iwamoto Y; Pezzino V; Trischitta V; Purrello F; Vigneri R
    Diabetes Care; 1984; 7 Suppl 1():54-8. PubMed ID: 6734405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral antidiabetic drugs on lipase activity in vitro.
    Holmes JH; Sapeika N; Zwarenstein H
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):667-70. PubMed ID: 1179037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of the effect of a principle extracted from Eugenia Jambolana bark with NN-methyldimethyl biguanide and glybutamide on induced hypoglycemia in normal rats].
    Ratsimamanga AR; Lefournier-Contensou C; Bibal-Prot P
    C R Acad Hebd Seances Acad Sci D; 1972 Aug; 275(8):913-5. PubMed ID: 4628567
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical use of oral hypoglycemic agents.
    Hagg SA
    Am J Hosp Pharm; 1976 Sep; 33(9):943-7. PubMed ID: 790951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thyroid function in diabetics treated with sulfonylurea and biguanides].
    Kasperska-Czyzykowa T; Czech W; Sawicki Z; Woy-Wojciechowski J; ZuĊ‚awnik W
    Pol Arch Med Wewn; 1978 Mar; 59(3):275-83. PubMed ID: 580962
    [No Abstract]   [Full Text] [Related]  

  • 13. [Differential therapy using oral antidiabetics].
    Mehnert H
    Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin and oral hypoglycaemic agents. I. Physiological and clinical pharmacological aspects.
    Breidahl HD; Ennis GC; Martin FI; Stawell JR; Taft P
    Drugs; 1972; 3(1):79-107. PubMed ID: 4559811
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral hypoglycemic agents.
    Shen SW; Bressler R
    Dis Mon; 1976 Jan; 22(4):1-35. PubMed ID: 765082
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral hypoglycaemic agents. An update.
    Asmal AC; Marble A
    Drugs; 1984 Jul; 28(1):62-78. PubMed ID: 6378583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral hypoglycemic agents--overview].
    Sakamoto N; Uno T
    Nihon Rinsho; 1997 Nov; 55 Suppl():94-8. PubMed ID: 9434450
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
    Losert W; Hoder A; Scholz C
    Arzneimittelforschung; 1975 Feb; 25(2):170-9. PubMed ID: 804311
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacologic profile of oral antidiabetic agents].
    Okubo M; Yamane K; Kohno N
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():310-6. PubMed ID: 12387011
    [No Abstract]   [Full Text] [Related]  

  • 20. [The pharmacological blockade of protein glycosylation in diabetes mellitus using sulfonylurea derivatives and biguanides].
    Lebedeva EA
    Eksp Klin Farmakol; 1996; 59(5):40-2. PubMed ID: 9026209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.